Natural product extracts for ischemic stroke: a methodological evaluation and meta-epidemiological analysis
SRs/MAs on NPEs for ischemic stroke exhibit suboptimal methodological quality and high redundancy. Although PRISMA statement improved the methodological quality, prospective protocol registration and transparent search process are imperative to enhance evidence synthesis.
Authors
- Xu Pang
- Lei Li (ORCID: https://orcid.org/0000-0001-8723-3461)
- Peipei Du (ORCID: https://orcid.org/0000-0001-6582-8384)
- Jierong Gao
- Chi Zhang
- Minghui Zhang
- Yao Lu
- Sijin Wang
- Ziwen Xu
Institutions
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Beijing Chang'an Integrated Traditional Chinese and Western Medicine Hospital (CN)
- Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2026-01-05
- DOI
- https://doi.org/10.3389/fphar.2025.1730699
- Primary Topic
- Ginkgo biloba and Cashew Applications
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Key Research and Development Program of China